[go: up one dir, main page]

TR201009168A2 - Suda dağılan sefpodoksim proksetil formülasyonları. - Google Patents

Suda dağılan sefpodoksim proksetil formülasyonları.

Info

Publication number
TR201009168A2
TR201009168A2 TR2010/09168A TR201009168A TR201009168A2 TR 201009168 A2 TR201009168 A2 TR 201009168A2 TR 2010/09168 A TR2010/09168 A TR 2010/09168A TR 201009168 A TR201009168 A TR 201009168A TR 201009168 A2 TR201009168 A2 TR 201009168A2
Authority
TR
Turkey
Prior art keywords
formulations
water dispersible
cefpodoxime proxetil
proxetil
cefpodoxime
Prior art date
Application number
TR2010/09168A
Other languages
English (en)
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/09168A priority Critical patent/TR201009168A2/xx
Priority to PCT/TR2011/000255 priority patent/WO2012060790A2/fr
Priority to PCT/TR2011/000251 priority patent/WO2012060786A2/fr
Publication of TR201009168A2 publication Critical patent/TR201009168A2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR2010/09168A 2010-11-05 2010-11-05 Suda dağılan sefpodoksim proksetil formülasyonları. TR201009168A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2010/09168A TR201009168A2 (tr) 2010-11-05 2010-11-05 Suda dağılan sefpodoksim proksetil formülasyonları.
PCT/TR2011/000255 WO2012060790A2 (fr) 2010-11-05 2011-11-03 Formulations de cefpodoxime proxétil dispersibles dans l'eau
PCT/TR2011/000251 WO2012060786A2 (fr) 2010-11-05 2011-11-03 Formulations de proxétil cefpodoxime comprenant un agent de viscosité

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/09168A TR201009168A2 (tr) 2010-11-05 2010-11-05 Suda dağılan sefpodoksim proksetil formülasyonları.

Publications (1)

Publication Number Publication Date
TR201009168A2 true TR201009168A2 (tr) 2012-05-21

Family

ID=45446166

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/09168A TR201009168A2 (tr) 2010-11-05 2010-11-05 Suda dağılan sefpodoksim proksetil formülasyonları.

Country Status (2)

Country Link
TR (1) TR201009168A2 (fr)
WO (2) WO2012060786A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013151517A1 (fr) * 2012-04-04 2013-10-10 Mahmut Bilgic Formulations en comprimés comprenant du cefpodoxime proxétil et de l'acide clavulanique
CN103142506B (zh) * 2013-04-03 2015-02-25 天津医药集团津康制药有限公司 一种头孢泊肟酯颗粒剂及其制备方法
CN103230367B (zh) * 2013-05-07 2014-11-12 山东罗欣药业集团股份有限公司 一种头孢泊肟酯组合物干混悬剂及其制备方法
RU2017121505A (ru) * 2014-12-01 2019-01-09 Сан Фармасьютикал Индастриз Лимитед Композиция цефподоксима проксетила с пролонгированным высвобождением

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486425A (en) 1980-09-30 1984-12-04 Sankyo Company Limited 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
KR20030087009A (ko) * 2001-02-27 2003-11-12 랜박시 래보러터리스 리미티드 세프포독심 프록세틸의 경구용 약학 조성물
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
KR20050062514A (ko) * 2002-07-16 2005-06-23 랜박시 래보러터리스 리미티드 경구 투여용 분산성 정제
EP1883393A2 (fr) * 2005-05-05 2008-02-06 Lupin Ltd. Compositions pharmaceutiques stabilisees de cephalosporines
TR201002878A2 (tr) * 2010-04-13 2011-10-21 Bi̇lgi̇ç Mahmut Sefpodoksim proksetil içeren farmasötik bileşimler.

Also Published As

Publication number Publication date
WO2012060790A2 (fr) 2012-05-10
WO2012060786A2 (fr) 2012-05-10
WO2012060790A3 (fr) 2012-09-20
WO2012060786A3 (fr) 2012-07-26

Similar Documents

Publication Publication Date Title
JOP20180102B1 (ar) مركب صيدلاني
SMT201600216B (it) Ottaidropirrolo[3,4.c]pirroli disostituiti come modulatori del recettore di orexina
PH12013500360B1 (en) Pesticidal compositions
BR112012029917A2 (pt) composições de nanotransportador com adjuvante desacoplado
EA201390586A1 (ru) Последовательности crispr-cas lactococcus
JOP20200039A1 (ar) مُستحضر صيدلي يشتمل على hcg مأشوب
IT1397255B1 (it) Struttura di impianto dentale perfezionato.
CL2014000815A1 (es) Compuestos derivados de 2-metoxibenzamidas insecticidas; composiciones insecticidas.
EA201300733A1 (ru) Рекомбинантные микобактерии в качестве вакцины
IT1398957B1 (it) Apparato di pulizia di gas prodotto da gassificatori.
HRP20181437T1 (hr) Postupak proizvodnje (3s,3s') 4,4' disulfanedilbis (3-aminobutan-1-sulfonske kiseline)
TR201009168A2 (tr) Suda dağılan sefpodoksim proksetil formülasyonları.
WO2011029536A3 (fr) Utilisation de céto-énols cycliques pour lutter contre des bactéries pathogènes chez les végétaux
TR201007106A1 (tr) Sefpodoksim proksetil formülasyonları.
TR201002878A2 (tr) Sefpodoksim proksetil içeren farmasötik bileşimler.
MY165088A (en) Pharmaceutical compositions comprising alisporivir
ITTO20110857A1 (it) Procedimento per la produzione di cicloesanonossina.
IT1400666B1 (it) Procedimento per la sintesi di 5-amino, 1-fenil, 3-ciano, 4-trifluorometil sulfinil pirazoli.
WO2012004073A3 (fr) UTILISATION DE β-ISOPHORONE COMME SOLVANT
EA201300607A8 (ru) Ионная жидкость ротиготина
IT1406067B1 (it) Composizioni eudermiche.
TR201007107A1 (tr) Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları.
IT1399582B1 (it) Sistema di stabilizzazione out-lift.
IN2014DN05954A (fr)
UA42144U (ru) Применение йодида s,s-диизопропил-n-(1-метил-3-пиридоил)сульфилимина как индуктора накопления фосфора растениями